Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Stayble Therapeutics AB

Closing information (x1000 EUR)

Closing information 2023/12 2022/12 2021/12
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 21 Less Arrow 3 More Arrow 6
Earnings before taxes -2,139 Less Arrow -2,204 More Arrow -1,182
EBITDA -2,159 Less Arrow -2,228 More Arrow -1,186
Total assets 1,956 Less Arrow 1,721 More Arrow 4,267
Current assets 1,447 Less Arrow 1,213 More Arrow 3,715
Current liabilities 392 Less Arrow 271 More Arrow 291
Equity capital 1,488 Less Arrow 1,373 More Arrow 3,892
- share capital 372 Less Arrow 162 More Arrow 176
Employees (average) 3 Equal arrow 3 Equal arrow 3

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency 76.1% More Arrow 79.8% More Arrow 91.2%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -108.3% Less Arrow -127.9% More Arrow -27.6%
Current ratio 369.1% More Arrow 447.6% More Arrow 1276.6%
Return on equity (ROE) -143.8% Less Arrow -160.5% More Arrow -30.4%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 0 Equal arrow 0 More Arrow 1
Chg. No. of employees % 0% Equal arrow 0% More Arrow 50%

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.